Nisa Investment Advisors
VERA icon

Nisa Investment Advisors’s Vera Therapeutics VERA Stock Holding History

Nisa Investment Advisors’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$50.1K Buy
1,167
+604
+107% +$22.5K ﹤0.01% 1856
2026
Q1 		$22.6K Buy
563
+6
+1% +$259 ﹤0.01% 1962
2025
Q4 		$28.2K Sell
557
-93
-14% -$3.3K ﹤0.01% 1811
2025
Q3 		$18.9K Sell
650
-168
-21% -$3.88K ﹤0.01% 2030
2025
Q2 		$19.3K Buy
818
+138
+20% +$3.1K ﹤0.01% 1962
2025
Q1 		$16.3K Buy
680
+502
+282% +$16.1K ﹤0.01% 1962
2024
Q4 		$7.53K Buy
178
+57
+47% +$2.52K ﹤0.01% 2194
2024
Q3 		$5.35K Buy
121
+54
+81% +$2.05K ﹤0.01% 2212
2024
Q2 		$2.42K Buy
67
+8
+14% +$317 ﹤0.01% 2358
2024
Q1 		$2.54K Buy
59
+29
+97% +$1.03K ﹤0.01% 2195
2023
Q4 		$461 Sell
30
-580
-95% -$7.37K ﹤0.01% 2425
2023
Q3 		$8.36K Buy
610
+580
+1,933% +$9.95K ﹤0.01% 2211
2023
Q2 		$482 Buy
30
+19
+173% +$172 ﹤0.01% 2569
2023
Q1 		$0 Sell
11
-6
-35% -$46 ﹤0.01% 2720
2022
Q4 		$0 Buy
+17
New +$308 ﹤0.01% 2739

Other funds holding VERA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.81B AUM 192.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Nisa Investment Advisors's VERA Position: Q2 2026 in Review

Nisa Investment Advisors increased its Vera Therapeutics (VERA) stake by 107% in Q2 2026, buying an estimated $22.5K and bringing the position to 1,167 shares worth $50.1K. The position accounts for ﹤0.01% of the portfolio, ranked #1856.

Nisa Investment Advisors first reported a position in VERA in Q4 2022 and has held it in 15 quarters since. 219 funds tracked by Wall St. Rank hold VERA as of Q2 2026.

  • Nisa Investment Advisors held 1,167 shares of Vera Therapeutics worth $50.1K as of Q2 2026.
  • Nisa Investment Advisors bought 604 Vera Therapeutics shares in Q2 2026, an estimated $22.5K.
  • Vera Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #1856 holding.
  • Nisa Investment Advisors first reported a position in Vera Therapeutics in Q4 2022 and has held it in 15 quarters since.
  • 219 funds tracked by Wall St. Rank held Vera Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.